(Q37207137)

18 August 2017

Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort (English)

1 reference

18 August 2017

0 references

1 reference

8

Karl Egerer

0 references

Cornelia Dähnrich

2

object named as

Cornelia Dähnrich

0 references

Gabriela Riemekasten

12

object named as

Gabriela Riemekasten

1 reference

18 August 2017

9

Falk Hiepe

0 references

Gerd-Rüdiger Burmester

10

object named as

Gerd R Burmester

1 reference

18 August 2017

Katharina Hanke

1

1 reference

18 August 2017

Cornelia Dähnrich

2

1 reference

18 August 2017

Claudia S Brückner

3

1 reference

18 August 2017

Dörte Huscher

4

1 reference

18 August 2017

Mike Becker

5

1 reference

18 August 2017

Anthonina Jansen

6

1 reference

18 August 2017

Wolfgang Meyer

7

1 reference

18 August 2017

Falk Hiepe

9

1 reference

18 August 2017

Wolfgang Schlumberger

11

1 reference

18 August 2017

21 February 2009

1 reference

Arthritis Research and Therapy

18 August 2017

1 reference

18 August 2017

11

1 reference

18 August 2017

1

1 reference

18 August 2017

R28

1 reference

Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Antitopoisomerase 1 antibodies in systemic sclerosis: how to improve the detection?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688262

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

3 September 2018

1 reference

12 December 2020

Unclassified or undifferentiated connective tissue disease

1 reference

12 December 2020

Sensitivity and specificity of immunological methods for the detection of anti-topoisomerase I (Scl70) autoantibodies: results of a multicenter study. The Italian Society of Laboratory Medicine Study Group on the Diagnosis of Autoimmune diseases

1 reference

12 December 2020

Scleroderma overlap syndromes

1 reference

12 December 2020

Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis

1 reference

12 December 2020

Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?

1 reference

12 December 2020

A disease severity scale for systemic sclerosis: development and testing

1 reference

12 December 2020

Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice

1 reference

12 December 2020

Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis

1 reference

12 December 2020

[Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS)]

1 reference

12 December 2020

Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival

1 reference

12 December 2020

[Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features]

1 reference

12 December 2020

Correlation of serum anti‐DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis

1 reference

12 December 2020

Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR2622

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

19232127

1 reference